Delhi-based pharmaceutical company Mankind Pharma, known for its contraceptive products, is all set to make its foray into the diagnostic laboratories business with Pathkind. The Juneja family-promoted company wants to exploit the opportunity that Dr Lal PathLabs, Metropolis and SRL Diagnostics have tapped by making the sector more organised.
The diagnostic space is expected to make Rs 60,000 crore in revenue in 2017-18, compared to Rs 37,700 crore in 2014-15, according to Dr Lal PathLabs’ annual report for 2016. It is highly fragmented with standalone centres accounting for 45-50% of the market and organised ones having 25-30% share, while hospital-based